Search Results - "Venturo, I"

Refine Results
  1. 1

    Selective Changes in Expression of HLA Class I Polymorphic Determinants in Human Solid Tumors by Natali, P. G., Nicotra, M. R., Bigotti, A., Venturo, I., Marcenaro, L., Giacomini, P., Russo, C.

    “…Analysis of surgical biopsies with monoclonal antibodies (mAbs) to framework determinants of major histocompatibility complex class I antigens has shown that…”
    Get full text
    Journal Article
  2. 2

    Potential usefulness of serum p53 for laboratory management of plasma cell dyscrasias by Greco, C, Alvino, S, Del Monte, G, Venturo, I, Lopez, M

    “…We measured the serum levels of p53 mutant protein (p53M-ELISA) in 65 patients with plasma cell dyscrasia (PCD) and compared them with some conventional…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Integrin (α6/β4) expression in human lung cancer as monitored by specific monoclonal antibodies by COSTANTINI, R. M, FALCIONI, R, BATTISTA, P, ZUPI, G, KENNEL, S. J, COLASANTE, A, VENTURO, I, GALLO CURCIO, C, SACCHI, A

    Published in Cancer research (Chicago, Ill.) (15-09-1990)
    “…In this study, the expression of the alpha 6/beta 4 integrin complex was analyzed in human lung carcinomas both in vitro and in vivo, using two monoclonal…”
    Get full text
    Journal Article
  5. 5

    Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies by MOTTOLESE, M, VENTURO, I, RINALDI, M, LOPEZ, M, BIGOTTI, G, BENEVOLO, M, NATALI, P. G

    Published in British journal of cancer (01-01-1997)
    “…The longer survival of neoplastic patients achieved through improvements of therapeutic regimens has increased the relative risk of developing a second primary…”
    Get full text
    Journal Article
  6. 6

    Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component by Greco, C., Ameglio, F., Alvino, F., Mosiello, A., Cianciulli, A. M., Venturo, I., Del Monte, G., Giampaolo, M., Tong, A. W., Gandolfo, G. M.

    Published in Cell proliferation (01-08-1999)
    “… As at present only a long‐term follow‐up can fully determine whether monoclonal gammapathies of undetermined significance (MGUS) will evolve into multiple…”
    Get full text
    Journal Article
  7. 7

    Immunocytochemical diagnosis of amelanotic metastatic melanoma using monoclonal antibodies HMB-45 and Ep1-3 by Mottolese, M, Venturo, I, Benevolo, M, Di Filippo, F, Lopez, M, Bigotti, A, Natali, P G

    Published in Melanoma research (01-02-1994)
    “…The analysis of fine-needle aspirates and effusions has proved to be a valuable tool for the cytological identification of metastatic melanoma. Nevertheless,…”
    Get more information
    Journal Article
  8. 8

    Antigenic modulation of metastatic breast and ovary carcinoma cells by intracavitary injection of IFN-α by GIACOMINI, P, MOTTOLESE, M, FRAIOLI, R, BENEVOLO, M, VENTURO, I, NATALI, P. G

    Published in British journal of cancer (01-08-1992)
    “…Antigenic modulation of major histocompatibility and tumour associated antigens was observed in neoplastic cells obtained from patients with pleural and…”
    Get full text
    Journal Article
  9. 9

    Vla-3 distribution in normal and neoplastic non-lymphoid human tissues by Bartolazzi, A, Cerboni, C, Full, C, Valentini, C, Natali, P G, Venturo, I, Bigotti, A

    Published in Pathology, research and practice (01-05-1993)
    “…Using monoclonal antibody (mAb) M-Kid 2 to the alpha 3 beta 1 heterodimer, we have evaluated immunohistochemically the in vivo expression of the Vla-3 integrin…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Second generation monoclonal antibodies to the human integrin alpha 6 beta 4 by Kennel, S J, Epler, R G, Lankford, T K, Foote, L J, Dickas, V, Canamucio, M, Cavalierie, R, Cosimelli, M, Venturo, I, Falcioni, R

    Published in Hybridoma (01-06-1990)
    “…Second generation monoclonal antibodies to the alpha 6 beta 4 subunits of human integrins have been prepared. MAbs 450-9D, 10D, and 11A1 react at different…”
    Get more information
    Journal Article
  12. 12

    Somatostatin receptor imaging in small cell lung cancer using 111In-DTPA-octreotide: a preliminary study by Maini, C L, Tofani, A, Venturo, I, Pigorini, F, Sciuto, R, Semprebene, A, Boni, S, Giunta, S, Lopez, M

    Published in Nuclear medicine communications (01-11-1993)
    “…Small cell lung cancer is a common and aggressive disease. Combined multiagent chemotherapy and radiotherapy can improve short-term prognosis, but long-term…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma by MOTTOLESE, M, VENTURO, I, DIGIESI, G, PERRONE DONNORSO, R, BIGOTTI, A, MURARO, R, ALUFFI, A, NATALI, P. G

    Published in British journal of cancer (01-04-1990)
    “…During the course of colon-rectum tumours a number of clinical events may occur in which conventional cytopathology can provide only a partial contribution to…”
    Get full text
    Journal Article
  16. 16

    Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture by Mottolese, M, Cianciulli, A, Venturo, I, Perrone Donnorso, R, Salzano, M, Benevolo, M, Bigotti, G, Natali, P G

    Published in Diagnostic cytopathology (01-01-1992)
    “…The use of a selected panel of monoclonal antibodies (MoAb) to tumor associated antigens (TAA) in immunocytochemical (IIC) tests has been shown, in a…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    111In-octreotide scintigraphy in small cell lung cancer by Semprebene, A, Ferraironi, A, Franciotti, G, Venturo, I, Giunta, S, Lopez, M, Maini, C L

    Published in The quarterly journal of nuclear medicine (01-12-1995)
    “…Somatostatin receptors have been identified on the cellular surface of a subset of patients with small cell lung cancer (SCLC) and may be associated with a…”
    Get more information
    Journal Article
  20. 20

    Human mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8 super(+) T-cell immune response by Modugno, F D, Bronzi, G, Scanlan, MJ, Del Bello, D, Cascioli, S, Venturo, I, Botti, C, Nicotra, M R, Mottolese, M, Natali, P G, Santoni, A, Jager, E, Nistico, P

    Published in International journal of cancer (01-01-2004)
    “…Screening of a cDNA expression library from a primary breast tumor with the autologous patient serum led to the isolation of 6 cDNA clones corresponding to 3…”
    Get full text
    Journal Article